MOREPENLABNSEMorepen Laboratories Limited· PharmaceuticalsHighNegative
Announced Mon, 5 May · 16:08 IST

Morepen Laboratories Limited has informed the Exchange about change in Senior Management Personnel on account of resignation.

Kmp ResignedManagement Changes View source PDF

MOREPENLAB · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Morepen Laboratories informed the exchanges that Mr. Naresh Sharma, Vice President – Operations (API) and Factory Manager, has resigned due to personal reasons, effective May 5, 2025. The disclosure was made under Regulation 30 of the SEBI Listing Regulations, along with the resignation email as supporting evidence. Mr. Sharma's email cited unavoidable personal circumstances as the reason for stepping down. No replacement or interim arrangement has been mentioned in this filing.

Likely market impact

This is a mid-to-senior operational-level exit rather than a top leadership change, so the direct impact on stock price or shareholder value is likely limited. Investors may watch for any disruption in API operations or a timely successor appointment, but the resignation itself is routine in nature.